Rankings
▼
Calendar
TEVA FY 2015 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$36B
FY 2015 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$19.7B
-3.1% YoY
Gross Profit
$11.4B
57.8% margin
Operating Income
$3.4B
17.1% margin
Net Income
$1.6B
8.1% margin
EPS (Diluted)
$1.82
Cash Flow
Operating Cash Flow
$5.5B
Free Cash Flow
$4.8B
Stock-Based Comp.
$117M
Balance Sheet
Total Assets
$54.3B
Total Liabilities
$24.3B
Stockholders' Equity
$29.8B
Cash & Equivalents
$6.9B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$19.7B
$20.3B
-3.1%
Gross Profit
$11.4B
$11.1B
+2.7%
Operating Income
$3.4B
$4.0B
-15.2%
Net Income
$1.6B
$3.1B
-48.0%
← FY 2014
All Quarters
Q1 2016 →